...these treatment-resistant patients were some atypical antipsychotics or electroconvulsive therapy. Atypical antipsychotics, such as Symbyaxolanzapine/fluoxetine...
...Symbyaxolanzapine/fluoxetine to treat acute treatment-resistant depression in adults. The company also said it updated Symbyax's... ...depressive episodes associated with bipolar disorder. Eli Lilly and Co. (NYSE:LLY), Indianapolis, Ind. Product: Symbyaxolanzapine/fluoxetine...
...be particularly interesting to probe this model with relatively novel treatments such as lamotrigine or olanzapine/fluoxetine... ...have implications for better relating the present transgenic model to distinct clinical subpopulations." Lilly markets Symbyax...
...LLY added a boxed warning to the label for Symbyaxolanzapine/fluoxetine to warn that antidepressants increase... ...antidepressants increase the risk of suicidal thinking and behavior in children, adolescents and young adults. Symbyax... ...depressive episodes associated with bipolar disorder. Eli Lilly and Co. (LLY), Indianapolis, Ind. Product: Symbyaxolanzapine/fluoxetine...
...Healthcare Professional" letter and updated the label for the atypical antipsychotics Zyprexa olanzapine and Symbyaxolanzapine/fluoxetine... ...CAFE postmarketing studies. Eli Lilly and Co. (LLY), Indianapolis, Ind. Product: Zyprexa olanzapine and Symbyaxolanzapine/fluoxetine...
...LLY received an FDA approvable letter in response to an sNDA for Symbyax olanzapine and fluoxetine... ...depressive episodes associated with bipolar disorder. Eli Lilly and Co. (LLY), Indianapolis, Ind. Product: Symbyaxolanzapine/fluoxetine...